B. Riley Wealth Advisors Inc. Trims Stake in DaVita Inc. (NYSE:DVA)

B. Riley Wealth Advisors Inc. cut its stake in DaVita Inc. (NYSE:DVA) by 23.6% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 3,154 shares of the company’s stock after selling 976 shares during the period. B. Riley Wealth Advisors Inc.’s holdings in DaVita were worth $513,000 at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. Transcendent Capital Group LLC bought a new position in shares of DaVita in the 3rd quarter worth approximately $25,000. Blue Trust Inc. raised its holdings in DaVita by 58.6% in the second quarter. Blue Trust Inc. now owns 211 shares of the company’s stock worth $29,000 after purchasing an additional 78 shares in the last quarter. Family Firm Inc. purchased a new position in DaVita during the second quarter valued at $43,000. Quarry LP bought a new stake in shares of DaVita during the 3rd quarter valued at $60,000. Finally, Point72 Hong Kong Ltd purchased a new stake in shares of DaVita in the 2nd quarter worth about $68,000. 90.12% of the stock is owned by institutional investors.

DaVita Stock Up 0.5 %

NYSE:DVA opened at $147.54 on Friday. The company has a debt-to-equity ratio of 15.78, a quick ratio of 1.33 and a current ratio of 1.37. The firm has a market cap of $12.10 billion, a P/E ratio of 15.92, a P/E/G ratio of 0.86 and a beta of 0.90. DaVita Inc. has a fifty-two week low of $103.40 and a fifty-two week high of $169.51. The firm has a 50-day simple moving average of $157.18 and a two-hundred day simple moving average of $150.83.

DaVita (NYSE:DVA) last announced its quarterly earnings data on Tuesday, October 29th. The company reported $2.59 earnings per share for the quarter, missing analysts’ consensus estimates of $2.76 by ($0.17). DaVita had a return on equity of 88.18% and a net margin of 6.53%. The firm had revenue of $3.26 billion during the quarter, compared to analysts’ expectations of $3.25 billion. During the same quarter in the previous year, the firm earned $2.85 earnings per share. DaVita’s revenue was up 4.6% on a year-over-year basis. Analysts predict that DaVita Inc. will post 9.71 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of research analysts recently issued reports on the stock. Barclays lifted their price target on shares of DaVita from $150.00 to $164.00 and gave the company an “equal weight” rating in a research report on Thursday, October 31st. Truist Financial lifted their target price on shares of DaVita from $165.00 to $175.00 and gave the company a “hold” rating in a report on Monday, October 7th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $161.80.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.